Eon Wellbutrin SR Generic Launch Delayed By Two Restraining Orders
Executive Summary
Eon's launch of generic bupropion extended-release 100 mg (GlaxoSmithKline's Wellbutrin SR) depends on the resolution of two temporary restraining orders: one from GSK and one from Andrx
You may also be interested in...
Impax/Teva Wellbutrin SR Generic Cleared To Launch By Court, FDA
Impax' bupropion sustained-release generic is cleared for launch following an appeals court ruling that the company does not infringe GlaxoSmithKline's Wellbutrin SR/Zyban patent
Impax/Teva Wellbutrin SR Generic Cleared To Launch By Court, FDA
Impax' bupropion sustained-release generic is cleared for launch following an appeals court ruling that the company does not infringe GlaxoSmithKline's Wellbutrin SR/Zyban patent
Eon Wellbutrin SR Generic Launch Blocked By Preliminary Injunction
GlaxoSmithKline will post a $3 mil. bond as part of a preliminary injunction the company obtained preventing the launch of Eon's 100 mg generic version of Wellbutrin SR